We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$21.6B
AUM Growth
+$2.85B
Cap. Flow
+$1.11B
Cap. Flow %
5.1%
Top 10 Hldgs %
30.93%
Holding
1,357
New
41
Increased
770
Reduced
236
Closed
79

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$203M
2
NOW icon
ServiceNow
NOW
+$181M
3
PSA icon
Public Storage
PSA
+$132M
4
ELS icon
Equity Lifestyle Properties
ELS
+$129M
5
OHI icon
Omega Healthcare
OHI
+$114M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$188M
2
SNOW icon
Snowflake
SNOW
+$152M
3
IRM icon
Iron Mountain
IRM
+$149M
4
PLD icon
Prologis
PLD
+$131M
5
AMT icon
American Tower
AMT
+$100M

Sector Composition

Rank Sector Weight
1 Real Estate 41.83%
2 Technology 20.16%
3 Communication Services 6.63%
4 Financials 5.64%
5 Consumer Discretionary 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
1151
Collegium Pharmaceutical
COLL
$1.16B
$5K ﹤0.01%
127
– –
HROW icon
1152
Harrow
HROW
$1.47B
$5K ﹤0.01%
110
– –
INVA icon
1153
Innoviva
INVA
$1.61B
$5K ﹤0.01%
238
+78
+49% +$1.44K
OCUL icon
1154
Ocular Therapeutix
OCUL
$1.85B
$5K ﹤0.01%
593
+186
+46% +$1.53K
PHAT icon
1155
Phathom Pharmaceuticals
PHAT
$930M
$5K ﹤0.01%
260
+93
+56% +$1.3K
SPRY icon
1156
ARS Pharmaceuticals
SPRY
$563M
$5K ﹤0.01%
367
– –
XLV icon
1157
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$5K ﹤0.01%
31
+9
+41% +$1.36K
ANAB icon
1158
AnaptysBio
ANAB
$1.54B
$4K ﹤0.01%
105
– –
ANIP icon
1159
ANI Pharmaceuticals
ANIP
$1.84B
$4K ﹤0.01%
70
– –
ARQT icon
1160
Arcutis Biotherapeutics
ARQT
$3.55B
$4K ﹤0.01%
439
– –
AUPH icon
1161
Aurinia Pharmaceuticals
AUPH
$1.92B
$4K ﹤0.01%
528
– –
AVDL
1162
DELISTED
Avadel Pharmaceuticals
AVDL
$4K ﹤0.01%
332
– –
CGEM icon
1163
Cullinan Oncology
CGEM
$1.07B
$4K ﹤0.01%
218
– –
COGT icon
1164
Cogent Biosciences
COGT
$6.95B
$4K ﹤0.01%
416
+135
+48% +$1.31K
DAWN
1165
DELISTED
Day One Biopharmaceuticals
DAWN
$4K ﹤0.01%
296
– –
DBC icon
1166
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
$4K ﹤0.01%
200
– –
ELVN icon
1167
Enliven Therapeutics
ELVN
$3.84B
$4K ﹤0.01%
152
– –
EOLS icon
1168
Evolus
EOLS
$410M
$4K ﹤0.01%
262
+100
+62% +$1.4K
GMAB icon
1169
Genmab
GMAB
$17.8B
$4K ﹤0.01%
159
+57
+56% +$1.52K
GRFS
1170
Grifois
GRFS
$5.44B
$4K ﹤0.01%
398
– –
IMCR icon
1171
Immunocore
IMCR
$1.7B
$4K ﹤0.01%
138
– –
MRVI icon
1172
Maravai LifeSciences
MRVI
$1.01B
$4K ﹤0.01%
490
– –
TARS icon
1173
Tarsus Pharmaceuticals
TARS
$2.57B
$4K ﹤0.01%
107
– –
TVTX icon
1174
Travere Therapeutics
TVTX
$5.2B
$4K ﹤0.01%
258
– –
VIR icon
1175
Vir Biotechnology
VIR
$1.49B
$4K ﹤0.01%
535
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2024 Portfolio in Review

As of Q3 2024, Daiwa Securities Group held 1,357 positions worth $21.6B, up 15% from $18.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $1.11B of net new capital in Q3 2024, opening 41 new positions and adding to 770 existing holdings. Its largest new stake was Lineage Inc: 465,245 shares worth $36.5M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $188M trimmed.

  • Daiwa Securities Group's largest Q3 2024 buy was Lineage Inc: 465,245 shares worth $36.5M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2024, an estimated $203M increase.
  • Daiwa Securities Group's biggest Q3 2024 reduction was Tesla, cutting an estimated $188M.
  • Daiwa Securities Group fully exited Lam Research in Q3 2024, selling an estimated $26.6M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $21.6B portfolio in Q3 2024.
  • Daiwa Securities Group opened 41 new positions and closed 79 in Q3 2024.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $21.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2024, filed 12 Nov 2024.